Physician

Joy Schechtman, DO

According to 2025 Medicare claims, Joy Schechtman, DO (NPI: 1649244716) practices rheumatology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is SUNVALLEY ARTHRITIS CENTER LTD (NPI: 1750423844; TIN: 860721995) and primary practice location at 85381-5025. Schechtman is affiliated with the Banner Health Network (ACO ID: A3229), participating under the MSSP model.

Schechtman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,184 traditional Medicare patients, billed 846,967 HCPCS/CPT codes, and received $10,196,312 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,366 prescription claims across 1,069 beneficiaries totaling $3,140,817 in drug costs, led by Ofev (Nintedanib Esylate). 2023 DME data shows 12 claims. Open Payments data shows 416 records totaling $401,212. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,687,509 to $10,196,312. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.1M$10M2015 Medicare payment: $2,687,509 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,079,211 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,678,867 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,160,756 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,988,545 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,818,402 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,196,982 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,887,947 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $8,293,806 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $10,196,312 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,074193,543$2,687,509
20161,030224,598$3,079,211
20171,028264,842$3,678,867
20181,041289,145$4,160,756
20191,049375,463$4,988,545
20201,024431,385$5,818,402
20211,125470,266$6,196,982
20221,177630,598$6,887,947
20231,158762,096$8,293,806
20241,184846,967$10,196,312

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.3M2015 Drug cost: $3,134,793 (USD; Tot_Drug_Cst)2016 Drug cost: $2,617,909 (USD; Tot_Drug_Cst)2017 Drug cost: $2,373,233 (USD; Tot_Drug_Cst)2018 Drug cost: $2,015,160 (USD; Tot_Drug_Cst)2019 Drug cost: $2,788,202 (USD; Tot_Drug_Cst)2020 Drug cost: $3,303,331 (USD; Tot_Drug_Cst)2021 Drug cost: $3,307,472 (USD; Tot_Drug_Cst)2022 Drug cost: $3,345,627 (USD; Tot_Drug_Cst)2023 Drug cost: $2,708,124 (USD; Tot_Drug_Cst)2024 Drug cost: $3,140,817 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20158558,948$3,134,793
20168158,131$2,617,909
20178707,352$2,373,233
20188405,543$2,015,160
20199077,388$2,788,202
20209147,983$3,303,331
20211,0078,259$3,307,472
20221,0598,446$3,345,627
20239636,164$2,708,124
20241,0697,366$3,140,817

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$39K2015 Medicare payment: $20,239 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $39,340 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $14,578 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $21,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,692 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,542 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $888 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20158589$20,239
20165051$39,340
20174444$14,578
20185659$21,635
20192727$3,692
2020N/RN/RN/R
2021N/R23$1,542
2022N/RN/RN/R
2023N/R12$888
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7564,450$100
77080Dxa bone density measurement of hip, pelvis, spine954956$40
J0897Injection, denosumab, 1 mg40739,383$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6723,575$13
96372Injection of drug or substance under skin or into muscle4731,849$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OfevNintedanib Esylate732,190$880,134
ProliaDenosumab29050,310$506,322
Evenity (2 Syringes)Romosozumab-Aqqg521,488$126,996
Xeljanz XrTofacitinib Citrate21630$118,089
Humira(Cf)Adalimumab12342$89,480

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.396$153,405Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.20$247,807Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joy Schechtman, DO?

Tedicare shows public-source Medicare data for Joy Schechtman, DO (NPI 1649244716), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joy Schechtman, DO have ACO affiliation data?

Joy Schechtman, DO is shown with ACO affiliation data for Banner Health Network (MSSP, ACO ID A3229).

What billing organization is linked to Joy Schechtman, DO?

Joy Schechtman, DO is linked to SUNVALLEY ARTHRITIS CENTER LTD (billing NPI 1750423844) in the available physician profile data.

Does Joy Schechtman, DO have Open Payments data?

Joy Schechtman, DO has 416 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.